Producer Price Inflation MoM in the United States increased to 0.70 percent in February from 0.50 percent in January of 2026. This dataset includes a chart with historical data for the United States Producer Price Inflation MoM.

Core Producer Prices MoM in the United States decreased to 0.50 percent in February from 0.80 percent in January of 2026. This dataset includes a chart with historical data for the United States Core Producer Prices MoM.

Enriched GO terms for proteins with lower than expected γ not identified when analyzing slowly evolving protein sequences.

In 2023, the U.S. Consumer Price Index was 309.42, and is projected to increase to 352.27 by 2029. The base period was 1982-84. The monthly CPI for all urban consumers in the U.S. can be accessed here. After a time of high inflation, the U.S. inflation rateis projected fall to two percent by 2027. United States Consumer Price Index ForecastIt is projected that the CPI will continue to rise year over year, reaching 325.6 in 2027. The Consumer Price Index of all urban consumers in previous years was lower, and has risen every year since 1992, except in 2009, when the CPI went from 215.30 in 2008 to 214.54 in 2009. The monthly unadjusted Consumer Price Index was 296.17 for the month of August in 2022. The U.S. CPI measures changes in the price of consumer goods and services purchased by households and is thought to reflect inflation in the U.S. as well as the health of the economy. The U.S. Bureau of Labor Statistics calculates the CPI and defines it as, "a measure of the average change over time in the prices paid by urban consumers for a market basket of consumer goods and services." The BLS records the price of thousands of goods and services month by month. They consider goods and services within eight main categories: food and beverage, housing, apparel, transportation, medical care, recreation, education, and other goods and services. They aggregate the data collected in order to compare how much it would cost a consumer to buy the same market basket of goods and services within one month or one year compared with the previous month or year. Given that the CPI is used to calculate U.S. inflation, the CPI influences the annual adjustments of many financial institutions in the United States, both private and public. Wages, social security payments, and pensions are all affected by the CPI.

Proton Pump Inhibitor Drug Market Outlook

As of 2023, the global market size for Proton Pump Inhibitor (PPI) Drugs has been estimated at approximately USD 10 billion, with a projected compound annual growth rate (CAGR) of 5% from 2024 to 2032. This growth trajectory anticipates an increase in the market size to around USD 15 billion by 2032. A key growth factor driving this market is the rising prevalence of gastroesophageal disorders, coupled with an increased awareness and accessibility of health care services, which has stimulated the demand for effective acid suppression therapies.

The burgeoning prevalence of gastrointestinal disorders such as Gastroesophageal Reflux Disease (GERD) and peptic ulcers represents a significant growth factor for the PPI drug market. GERD, in particular, affects a considerable portion of the global population, prompting an escalating need for effective management solutions. The increase in sedentary lifestyles and dietary habits that contribute to acid-related disorders is further propelling the market. Additionally, the growing elderly population, which is more susceptible to these disorders, underscores the expanding consumer base for proton pump inhibitors. As health systems worldwide put more emphasis on outpatient care, the reliance on pharmaceutical interventions like PPIs is becoming more pronounced.

Advancements in pharmaceutical research and development are also bolstering market growth. The introduction of novel formulations and the patent expiration of several blockbuster PPIs have paved the way for generic drug manufacturers, making these drugs more affordable and accessible. Also, ongoing research into the long-term safety and efficacy of PPIs is expected to yield newer, safer drug formulations, thereby expanding the potential market further. The role of PPI drugs in managing not just gastrointestinal conditions but also as adjunct therapy in preventing complications from medications like NSAIDs adds a layer of complexity and opportunity to this market.

On the regulatory front, the market is positively impacted by the efforts of healthcare bodies and governmental authorities to ensure the widespread availability and affordability of PPIs. Investment in healthcare infrastructure, especially in emerging economies, is enabling wider reach and adoption of these medications. Moreover, increasing patient awareness campaigns and the consequent rise in self-medication practices are also contributing to market growth. Nonetheless, these trends must balance the ongoing scrutiny regarding the overuse and long-term side effects of PPIs, which remain a point of concern for healthcare providers and regulators alike.

Regionally, the proton pump inhibitor market shows promising growth across various geographies, with North America and Europe currently dominating due to well-established healthcare systems and high disease prevalence. However, Asia Pacific is projected to exhibit the highest growth rate during the forecast period, driven by the increasing patient population suffering from gastrointestinal disorders and improving healthcare infrastructure. Latin America and the Middle East & Africa are also expected to witness substantial growth due to rising healthcare investments and increasing awareness of gastrointestinal health, although they currently represent a smaller share of the global market.

Drug Type Analysis

The proton pump inhibitor drug market is segmented by drug type into Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, and Others. Omeprazole, one of the oldest and most widely used PPIs, continues to hold a significant share due to its proven efficacy and affordability. Its availability in various forms, including over-the-counter options, makes it a popular choice among consumers. Omeprazole's extensive use is well-supported by a wealth of clinical data that underscores its effectiveness and safety, further cementing its position in the market. Patent expirations have also facilitated the entry of generic formulations, contributing to its broad accessibility and sustained market presence.

Esomeprazole, a more recent entrant compared to Omeprazole, is noteworthy for its improved pharmacokinetic profile and higher bioavailability, which have been shown to be beneficial in achieving better therapeutic outcomes for many patients. These characteristics have helped it gain a substantial foothold, particularly in markets where there is a high emphasis on clinical efficacy and patient compliance. Esomeprazole's success is also bolstered by aggressive marketing strategies and robust patent prot

Producer Prices in Poland decreased 2.30 percent in February of 2026 over the same month in the previous year. This dataset provides - Poland Producer Prices Change - actual values, historical data, forecast, chart, statistics, economic calendar and news.

Conserved synteny denotes evolutionary preserved gene order across species. It is not well understood to which degree functional relationships between genes are preserved in syntenic blocks. Here we investigate whether protein-coding genes conserved in mammalian syntenic blocks encode gene products that serve the common functional purpose of interacting at protein level, i.e. connectivity. High connectivity among protein-protein interactions (PPIs) was only moderately associated with conserved synteny on a genome-wide scale. However, we observed a smaller subset of 3.6% of all syntenic blocks with high-confidence PPIs that had significantly higher connectivity than expected by random. Additionally, syntenic blocks with high-confidence PPIs contained significantly more chromatin loops than the remaining blocks, indicating functional preservation among these syntenic blocks. Conserved synteny is typically defined by sequence similarity. In this study, we also examined whether a functional relationship, here PPI connectivity, can identify syntenic blocks independently of orthology. While orthology-based syntenic blocks with high-confident PPIs and the connectivity-based syntenic blocks largely overlapped, the connectivity-based approach identified additional syntenic blocks that were not found by conventional sequence-based methods alone. Additionally, the connectivity-based approach enabled identification of potential orthologous genes between species. Our analyses demonstrate that subsets of syntenic blocks are associated with highly connected proteins, and that PPI connectivity can be used to detect conserved synteny even if sequence conservation drifts beyond what orthology algorithms normally can identify.

Producer Price Inflation MoM in Canada decreased to 0.40 percent in February from 2.80 percent in January of 2026. This dataset includes a chart with historical data for Canada Producer Price Inflation MoM.

The Federal Reserve Bank of Cleveland provides daily “nowcasts” of inflation for two popular price indexes, the price index for personal consumption expenditures (PCE) and the Consumer Price Index (CPI). These nowcasts give a sense of where inflation is today. Released each business day.

Inflation Nowcasting Quarterly is a part of the Inflation Nowcasting indicator of the Federal Reserve Bank of Cleveland.

Consumer Price Index CPI in the United States increased to 326.79 points in February from 325.25 points in January of 2026. This dataset provides the latest reported value for - United States Consumer Price Index (CPI) - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.